Back to 2010: England's New CDF To Go Ahead
This article was originally published in Scrip
Executive Summary
England's new Cancer Drugs Fund is to go ahead with little change to proposals that have proved unpopular with companies. The Association of the British Pharmaceutical Industry says the new system will take patients and companies back to the situation in 2010 before the CDF was set up and that two thirds of CDF-financed drugs will be unavailable by the end of the year. Eisai has slammed the new fund, warning that drugs approved after the CDF closed its doors to funding new products will float in limbo with no clear means of getting to patients.